Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Marc Lasry: This Is The Right Time To Invest In Europe

Marc Lasry, CEO and cofounder of Avenue Capital Group, spoke on CNBC about his suggestions in investing in European market. “I think one of the things that you can do is you can sort of invest — this is the right time.” said Marc, “I think you want to be investing in europe because you’re buying assets today at extremely low prices.”


Marc said it will better for investor to target on the loans with high teens, without leverage, and on a senior basis. In Marc’s opinion, since Avenue Capital Group is a long only fund, he will not be short, and he is trying to figure out whether it’s possible to buy today at a pretty discount. At the meanwhile, he will hedge everything he invested in the market. But Marc still believes it’s difficult to invest in other Europe countries because people are still nervous about what will happen politically.

When being asked for his idea in northern Europe, Marc said although the legal system is far better in the north, people are over charged for investing in UK, Germany and Switzerland. And what actually happens there is those UK and Germany banks can’t take a reserve and they raise capital from the governments.

Marc talked about his opinion in the international Europe and in the United States. He thinks the environment in U.S. is much better, but people are still focus a lot on Europe. (see the full CNBC interview)

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!